Trials / Withdrawn
WithdrawnNCT03266081
Bupivacaine Epiphora Trial
Improving Epiphora & Ptosis With Bupivacaine
- Status
- Withdrawn
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- McMaster University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The objective of this study is to investigate quantitative improvement in excessive tearing after administration of Bupivacaine, a local anesthetic, into the affected eyelids.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 0.75% bupivacaine | topical anesthetic |
Timeline
- Start date
- 2015-04-01
- Primary completion
- 2022-08-23
- Completion
- 2022-08-23
- First posted
- 2017-08-29
- Last updated
- 2022-08-25
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03266081. Inclusion in this directory is not an endorsement.